Linly Stevens
Medical · Overland Park, KSNPI 1447217468
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by AbbVie at 58.5% of the total. Among medical clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 725 payments — averaging $153.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$65K
- E.r. Squibb & Sons, L.L.C.$32K
- Arcutis Biotherapeutics, Inc.$6K
- UCB, Inc.$2K
- LEO Pharma Inc.$1K
- Sun Pharmaceutical Industries Inc.$889
- plus $5K from 20 others
What the payments were for
- Consulting fees$13,54612%
- Speaking & faculty fees$61,41355%
- Travel & lodging$23,26421%
- Food & beverage$13,15912%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 199 | $65,137 |
| E.r. Squibb & Sons, L.L.C. | 90 | $31,866 |
| Arcutis Biotherapeutics, Inc. | 22 | $5,732 |
| UCB, Inc. | 32 | $1,756 |
| LEO Pharma Inc. | 62 | $1,042 |
| Sun Pharmaceutical Industries Inc. | 59 | $889 |
| Almirall LLC | 19 | $791 |
| Johnson & Johnson(2 entities) | 33 | $602 |
| Novartis | 29 | $540 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 29 | $498 |
| Dermavant Sciences, Inc. | 30 | $466 |
| Amgen | 20 | $387 |
| Pfizer | 29 | $372 |
| Galderma Laboratories, L.p. | 23 | $345 |
| Sanofi | 8 | $227 |
| Regeneron Healthcare Solutions, Inc. | 7 | $128 |
| Incyte Corporation | 7 | $119 |
| Journey Medical Corporation | 6 | $100 |
| Lilly USA, LLC | 5 | $98 |
| Dermira, Inc. | 4 | $84 |
| VYNE Pharmaceuticals Inc. | 4 | $60 |
| Boehringer Ingelheim | 1 | $58 |
| Janssen Scientific Affairs, LLC | 1 | $41 |
| Mayne Pharma Commercial LLC | 4 | $28 |
| EPI Health, LLC | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$111,402 in reported general payments places this provider in the 95th percentile of 205 medical providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 27 | $1,015 |
| Fluorouracil | 17 | $931 |
| Doxycycline Hyclate | 30 | $633 |
| Minocycline Hcl | 18 | $614 |
| Finasteride | 26 | $492 |
| Spironolactone | 15 | $81 |
Paid to pharmacies, not to this prescriber.
Other medical in Overland Park
- Courtney SteneOverland Park$22K
- Janella DewittOverland Park$19K
- Stephanie StroutOverland Park$3K
- Jillane JohnsonOverland Park$2K
- Abigail MoosOverland Park$2K
- Shana ArnholdShawnee$82K
- Richard AllenbachWichita$70K
- Laura LudlowTopeka$61K
- Anita KishOlathe$58K
- Kathryn WelchWichita$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.